Skip to main content
. 2012 Apr 26;48(1):52–56. doi: 10.4068/cmj.2012.48.1.52

FIG. 1.

FIG. 1

Changes in the NIHSS score in the two groups. There was a significant decrease in the NIHSS score at discharge in the urokinase treatment group (Group I). There was no significant difference before and after treatment in Group II. *p<0.05. NIHSS: National Institutes of Health Stroke Scale, Group I: urokinase treatment group, Group II: non-urokinase-treatment group.